111 related articles for article (PubMed ID: 15226040)
1. Clinical, demographic, and psychological characteristics of new, asymptomatic participants in a transvaginal ultrasound screening program for ovarian cancer.
Salsman JM; Pavlik E; Boerner LM; Andrykowski MA
Prev Med; 2004 Aug; 39(2):315-22. PubMed ID: 15226040
[TBL] [Abstract][Full Text] [Related]
2. Psychological response to test results in an ovarian cancer screening program: a prospective, longitudinal study.
Andrykowski MA; Boerner LM; Salsman JM; Pavlik E
Health Psychol; 2004 Nov; 23(6):622-30. PubMed ID: 15546230
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with return for routine annual screening in an ovarian cancer screening program.
Andrykowski MA; Zhang M; Pavlik EJ; Kryscio RJ
Gynecol Oncol; 2007 Mar; 104(3):695-701. PubMed ID: 17145075
[TBL] [Abstract][Full Text] [Related]
4. Demographic, clinical, dispositional, and social-environmental characteristics associated with psychological response to a false positive ovarian cancer screening test: a longitudinal study.
Wiggins AT; Pavlik EJ; Andrykowski MA
J Behav Med; 2018 Jun; 41(3):277-288. PubMed ID: 29071653
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.
van Nagell JR; DePriest PD; Reedy MB; Gallion HH; Ueland FR; Pavlik EJ; Kryscio RJ
Gynecol Oncol; 2000 Jun; 77(3):350-6. PubMed ID: 10831341
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer screening in women with a family history of breast or ovarian cancer.
Lacey JV; Greene MH; Buys SS; Reding D; Riley TL; Berg CD; Fagerstrom RM; Hartge P
Obstet Gynecol; 2006 Nov; 108(5):1176-84. PubMed ID: 17077240
[TBL] [Abstract][Full Text] [Related]
7. [Program for early detection of ovarian cancer for women as prophylaxis provided at a municipal hospital].
Cnota W; Sodowski K; Olesiak-Andryszczak M; Pilch-Kowalczyk M
Wiad Lek; 2004; 57 Suppl 1():43-7. PubMed ID: 15884203
[TBL] [Abstract][Full Text] [Related]
8. Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening.
Drescher CW; Nelson J; Peacock S; Andersen MR; McIntosh MW; Urban N
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):600-6. PubMed ID: 15066925
[TBL] [Abstract][Full Text] [Related]
9. Abnormal ovarian cancer screening test result: women's informational, psychological and practical needs.
Ryan PY; Graves KD; Pavlik EJ; Andrykowski MA
J Psychosoc Oncol; 2007; 25(4):1-18. PubMed ID: 18032262
[TBL] [Abstract][Full Text] [Related]
10. Psychological impact of screening for familial ovarian cancer.
Wardle FJ; Collins W; Pernet AL; Whitehead MI; Bourne TH; Campbell S
J Natl Cancer Inst; 1993 Apr; 85(8):653-7. PubMed ID: 8468723
[TBL] [Abstract][Full Text] [Related]
11. The search for meaning-Symptoms and transvaginal sonography screening for ovarian cancer: predicting malignancy.
Pavlik EJ; Saunders BA; Doran S; McHugh KW; Ueland FR; Desimone CP; Depriest PD; Ware RA; Kryscio RJ; van Nagell JR
Cancer; 2009 Aug; 115(16):3689-98. PubMed ID: 19603478
[TBL] [Abstract][Full Text] [Related]
12. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened.
van Nagell JR; DePriest PD; Ueland FR; DeSimone CP; Cooper AL; McDonald JM; Pavlik EJ; Kryscio RJ
Cancer; 2007 May; 109(9):1887-96. PubMed ID: 17373668
[TBL] [Abstract][Full Text] [Related]
13. Illness representations and distress in women undergoing screening for familial ovarian cancer.
Lancastle D; Brain K; Phelps C
Psychol Health; 2011 Dec; 26(12):1659-77. PubMed ID: 21736431
[TBL] [Abstract][Full Text] [Related]
14. Validity of self-reports of return for routine repeat screening in an ovarian cancer screening program.
Lykins EL; Pavlik EL; Andrykowski MA
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):490-3. PubMed ID: 17372244
[TBL] [Abstract][Full Text] [Related]
15. Serum CA 125 combined with transvaginal ultrasonography for ovarian cancer screening.
Roupa Z; Faros E; Raftopoulos V; Tzavelas G; Kotrotsiou E; Sotiropoulou P; Karanikola E; Skifta E; Ardavanis A
In Vivo; 2004; 18(6):831-6. PubMed ID: 15646829
[TBL] [Abstract][Full Text] [Related]
16. A Pap test does not screen for everything: nurse practitioner knowledge of ovarian cancer.
Loerzel VW; Hunt D; Rash E
J Am Assoc Nurse Pract; 2015 Mar; 27(3):124-30. PubMed ID: 25044820
[TBL] [Abstract][Full Text] [Related]
17. Psychological and behavioral impact of receipt of a "normal" ovarian cancer screening test.
Gaugler JE; Pavlik E; Salsman JM; Andrykowski MA
Prev Med; 2006 Jun; 42(6):463-70. PubMed ID: 16563482
[TBL] [Abstract][Full Text] [Related]
18. The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer.
Fishman DA; Cohen L; Blank SV; Shulman L; Singh D; Bozorgi K; Tamura R; Timor-Tritsch I; Schwartz PE
Am J Obstet Gynecol; 2005 Apr; 192(4):1214-21; discussion 1221-2. PubMed ID: 15846205
[TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer screening in asymptomatic postmenopausal women by transvaginal sonography.
Van Nagell JR; DePriest PD; Puls LE; Donaldson ES; Gallion HH; Pavlik EJ; Powell DE; Kryscio RJ
Cancer; 1991 Aug; 68(3):458-62. PubMed ID: 2065264
[TBL] [Abstract][Full Text] [Related]
20. Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer.
Menon U; Skates SJ; Lewis S; Rosenthal AN; Rufford B; Sibley K; Macdonald N; Dawnay A; Jeyarajah A; Bast RC; Oram D; Jacobs IJ
J Clin Oncol; 2005 Nov; 23(31):7919-26. PubMed ID: 16258091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
